Prelude Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Welcome to the Morgan Stanley Global Healthcare Conference. I'm Jeff Hung, one of the biotech analysts. For important disclosures, please see the Morgan Stanley Research Disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative. For this session, we have from Prelude Therapeutics, CEO, Kris Vaddi; CFO, Brian Piper; and CBO, Chris Pierce. Welcome. So for those who may not be familiar with Prelude, can you provide a brief introduction?
Absolutely. Thank you very much for the opportunity to participate at Morgan Stanley Healthcare Conference. We're very excited to be talking about Prelude and all the progress we've made so far. We're a precision oncology company, really small molecule based. We were about 5 years old now. We're a clinical stage
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |